HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rajesh Pahwa Selected Research

Essential Tremor (Essential Tremors)

7/2023Clinical benefit of transcutaneous afferent patterned stimulation (TAPS) in essential tremor patients with high unmet need: a secondary analysis of TAPS studies.
1/2021A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential Tremor.
1/2020Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor.
7/2019An Acute Randomized Controlled Trial of Noninvasive Peripheral Nerve Stimulation in Essential Tremor.
1/2019Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms.
7/2017Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial.
1/2013Deep brain stimulation for essential tremor.
7/2012Long-term benefits in quality of life after unilateral thalamic deep brain stimulation for essential tremor.
1/2008Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.
11/2007Levetiracetam is not effective for essential tremor.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rajesh Pahwa Research Topics

Disease

109Parkinson Disease (Parkinson's Disease)
03/2024 - 01/2003
34Dyskinesias (Dyskinesia)
03/2024 - 07/2004
23Tremor (Tremors)
07/2023 - 03/2002
19Essential Tremor (Essential Tremors)
07/2023 - 01/2003
8Nausea
10/2023 - 05/2003
7Psychotic Disorders (Schizoaffective Disorder)
10/2023 - 06/2011
7Movement Disorders (Movement Disorder)
01/2023 - 06/2006
6Sleepiness
04/2024 - 07/2004
5Disease Progression
07/2023 - 05/2014
5Edema (Dropsy)
12/2017 - 07/2004
4Hallucinations (Hallucination)
08/2023 - 07/2004
4Disorders of Excessive Somnolence (Hypersomnia)
08/2023 - 04/2006
4Parkinsonian Disorders (Parkinsonism)
07/2019 - 05/2003
4Hypokinesia (Bradykinesia)
05/2014 - 08/2005
3Cognitive Dysfunction
08/2023 - 06/2003
3Dizziness (Lightheadedness)
08/2023 - 02/2014
2Confusion (Bewilderment)
08/2023 - 05/2003
2Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
01/2023 - 01/2010
2Infections
01/2020 - 10/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 12/2003
2Dementia (Dementias)
01/2014 - 01/2003
2Dystonia (Limb Dystonia)
04/2006 - 01/2004
1Injection Site Reaction
03/2024
1Schizophrenia (Dementia Praecox)
08/2023
1Tauopathies
04/2023
1Vomiting
01/2023
1Kidney Calculi (Kidney Stone)
01/2021
1Heart Arrest (Cardiac Arrest)
01/2020
1Gastroparesis
01/2020
1Brain Edema (Cerebral Edema)
12/2017
1Sleep Wake Disorders
01/2015

Drug/Important Bio-Agent (IBA)

48Levodopa (L Dopa)FDA LinkGeneric
04/2024 - 07/2004
16Amantadine (Aman)FDA LinkGeneric
01/2022 - 09/2006
11levodopa drug combination carbidopa (Nakom)FDA LinkGeneric
10/2023 - 03/2006
8Dopamine Agonists (Dopamine Agonist)IBA
01/2023 - 09/2006
7Carbidopa (Lodosyn)FDA LinkGeneric
03/2024 - 07/2014
7SuspensionsIBA
10/2023 - 05/2017
5ApomorphineFDA Link
01/2023 - 07/2007
5ropinirole (Requip)FDA LinkGeneric
05/2010 - 07/2004
4Antipsychotic Agents (Antipsychotics)IBA
10/2019 - 03/2011
4pimavanserinIBA
10/2019 - 10/2015
4Dopamine (Intropin)FDA LinkGeneric
04/2015 - 07/2004
4Pramipexole (Mirapex)FDA LinkGeneric
01/2010 - 07/2004
3TabletsIBA
06/2022 - 04/2007
3rotigotineFDA Link
08/2013 - 04/2007
2propylene diquat (PDQ(+))IBA
04/2024 - 12/2022
2amsonic acid (DAS)IBA
01/2023 - 01/2010
2salicylhydroxamic acid (SHAM)IBA
01/2020 - 07/2019
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2017 - 01/2008
2safinamideIBA
02/2017 - 08/2014
2Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2017 - 01/2011
2Selegiline (E250)FDA LinkGeneric
01/2010 - 04/2007
2Leucine (L-Leucine)FDA Link
01/2008 - 01/2007
2Propranolol (Inderal)FDA LinkGeneric
01/2008 - 01/2003
2Primidone (Sertan)FDA LinkGeneric
01/2008 - 01/2003
2Levetiracetam (Keppra)FDA LinkGeneric
11/2007 - 05/2006
1Antidepressive Agents (Antidepressants)IBA
04/2024
1SolutionsIBA
03/2024
1Exenatide (Byetta)FDA Link
01/2024
1Glucagon-Like Peptide-1 ReceptorIBA
01/2024
1BenserazideIBA
10/2023
1catechol (pyrocatechol)IBA
10/2023
1TransferasesIBA
10/2023
1SEP-363856IBA
08/2023
1Trace amine-associated receptor 1IBA
08/2023
1Serotonin 5-HT1 Receptor AgonistsIBA
08/2023
15-HT1A Serotonin ReceptorIBA
08/2023
1Serotonin (5 Hydroxytryptamine)IBA
08/2023
1Protein Isoforms (Isoforms)IBA
04/2023
1trimethobenzamide (Ticon)FDA LinkGeneric
01/2023
1T34 toxinIBA
01/2023
1AntiemeticsIBA
01/2023
1Dopamine Receptors (Dopamine Receptor)IBA
01/2023
1Apolipoproteins AIBA
01/2023
1istradefyllineIBA
01/2022
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2021
1Uric Acid (Urate)IBA
01/2021
1InosineFDA Link
01/2021
1PowdersIBA
01/2019
1Dopa DecarboxylaseIBA
01/2019
1Clozapine (Clozaril)FDA LinkGeneric
12/2018
1Quetiapine Fumarate (Seroquel)FDA Link
12/2018
1Dexamethasone (Maxidex)FDA LinkGeneric
12/2017
1ioflupaneIBA
01/2017
16-bromo-2-naphthyl sulfate (BNS)IBA
08/2016
1insulin receptor-related receptor (IRR)IBA
10/2015
1pardoprunoxIBA
08/2014
1Delayed-Action PreparationsIBA
08/2014
1Monoamine Oxidase (MAO)IBA
08/2014
1Glutamic Acid (Glutamate)FDA Link
08/2014

Therapy/Procedure

39Deep Brain Stimulation
12/2022 - 03/2002
36Therapeutics
03/2024 - 01/2003
16Activities of Daily Living (ADL)
07/2023 - 08/2005
6Drug Therapy (Chemotherapy)
07/2023 - 01/2008
3Operative Surgical Procedures
06/2010 - 06/2006
2Qigong (Qi Gong)
01/2015 - 05/2006
2Microelectrodes
12/2010 - 01/2003
1Subcutaneous Infusions
03/2024
1Ambulatory Care (Outpatient Care)
01/2022
1Home Nursing (Nursing, Home)
07/2019